Nektar Therapeutics (NKTR) Institutional Ownership & Insider Trading
239 institutions reported holding Nektar Therapeutics shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 16 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NKTRNektar TherapeuticsFollow NKTR — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters239 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +34.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 239 | 36 | +34.4% | 98 | 65 | 38 | 34 |
| Mar 26 | 215 | 27 | +59.2% | 72 | 63 | 45 | 26 |
| Dec 25 | 178 | 17 | +18.3% | 46 | 48 | 42 | 28 |
| Sep 25 | 146 | 14 | +85.4% | 40 | 65 | 25 | 21 |
| Jun 25 | 104 | 8 | — | — | — | — | — |
| Mar 25 | 156 | 124 | -6.2% | 41 | 29 | 38 | 16 |
| Dec 24 | 145 | 133 | -7.2% | 45 | 13 | 32 | 13 |
| Sep 24 | 139 | 141 | -0.8% | 32 | 19 | 31 | 16 |
Nektar Therapeutics — questions
- Who owns Nektar Therapeutics stock?
- 239 institutions reported Nektar Therapeutics shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (14.8%), Two Seas Capital LP (9.1%), BlackRock, Inc. (8.6%).
- Are Nektar Therapeutics insiders buying or selling?
- 16 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Nektar Therapeutics's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.